Astronauts Tested Autonomous Ultrasound Tech in Orbit
The EchoFinder-2 experiment demonstrated AI-guided organ imaging to support remote medical care on future missions.
Updated on Oct. 2, 2026 in Space

Astronauts Jessica Meir, Jack Hathaway, and Sophie Adenot successfully performed autonomous medical imaging on the International Space Station last week. This research-stage study utilized augmented reality and artificial intelligence to facilitate ultrasound scans without ground support.
Why it matters
This technology aims to enable crews to conduct independent medical diagnostics, a requirement for long-duration Artemis missions where communication delays with Earth make real-time guidance impossible.
The CNES EchoFinder-2 experiment uses augmented reality and artificial intelligence to assist non-specialist users in performing medical imaging. This protocol is intended to supersede existing methods that rely on real-time expertise and troubleshooting from medical teams on Earth.
The players
Jessica Meir
An astronaut who performed medical imaging experiments on the International Space Station.
Jack Hathaway
An astronaut who participated in the EchoFinder-2 medical imaging research.
Sophie Adenot
An astronaut involved in the collaborative medical imaging trials.
CNES
The French national space agency responsible for developing the EchoFinder-2 medical research hardware.
The details
The procedure relies on autonomous guidance systems that provide real-time feedback to the operator, allowing them to capture ultrasound imagery of internal organs. By integrating augmented reality (AR) — a display technology that overlays digital information onto the user's field of view — with AI-driven image processing, the system ensures correct probe placement and data acquisition. Astronauts Meir, Hathaway, and Adenot rotated roles, with each crew member acting as both the practitioner and the patient to test the system's usability across different body types and scanning orientations.
Timeline
February 14: Jessica Meir and Jack Hathaway arrived at the International Space Station.
Last week: The crew conducted the CNES EchoFinder-2 medical imaging experiments.
Monday: The crew is scheduled to depart the International Space Station.
The Tech Race
This development follows the roadmap for the NASA Artemis missions to establish autonomous healthcare capabilities for deep-space travel. It marks a shift from relying on real-time Earth-based support to developing self-contained diagnostic systems for remote missions.
This research informs the development of remote monitoring tools that could eventually allow non-experts on Earth to perform diagnostic scans in underserved or isolated areas. These capabilities remain at the research stage, with long-term clinical and space-flight integration timelines currently unannounced.
The takeaway
The EchoFinder-2 experiment proves that autonomous, AI-guided medical imaging is technically feasible in microgravity environments. Future milestones to watch include the integration of these protocols into standard medical kits for the next phases of the Artemis lunar program.
What happens next
The astronauts involved in the study are scheduled to depart the International Space Station this coming Monday.
Further reading
For more on ongoing research in orbit, visit our Space section.
Source note: This article includes information reported by KULR-8 Local News.






